West Pharmaceutical Services (WST) Amortizatization of Intangibles (2009 - 2026)

West Pharmaceutical Services has disclosed Amortizatization of Intangibles across 18 years of filings, most recently posting $600000.0 for Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $600000.0, down 33.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (down 30.56% YoY), and the FY2025 annual result was $2.8 million, down 22.22% from the prior year.
• Amortizatization of Intangibles came in at $600000.0 for Q1 2026 at West Pharmaceutical Services, roughly flat from $600000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $1.3 million in Q4 2023 to a low of $500000.0 in Q2 2023.
• The 5-year median for Amortizatization of Intangibles is $900000.0 (2022), against an average of $841176.5.
• Across the five-year window, Amortizatization of Intangibles tumbled 52.38% in 2022 and soared 80.0% in 2024, its largest moves.
• West Pharmaceutical Services' Amortizatization of Intangibles stood at $1.0 million in 2022, then climbed by 30.0% to $1.3 million in 2023, then tumbled by 30.77% to $900000.0 in 2024, then plunged by 33.33% to $600000.0 in 2025, then changed by 0.0% to $600000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $600000.0 (Q1 2026), $600000.0 (Q4 2025), and $700000.0 (Q3 2025), per Business Quant data.